Monthly Archives: May 2020

Iron Mike will break his soul to get back in peak physical condition (Pictures: Instagram / @MikeTyson)

Heavyweight boxing legend Mike Tyson has explained his gruelling training regime as he bids to return to the ring and says he is still feeling weird after using stem-cell therapy.

The 53-year-old showed off his incredible, age-defying speed and power in training footage he uploaded to Instagram last week, declaring he was back and ready to take part in exhibition fights for charity.

Iron Mike has already been inundated with potential challengers to fight, with old heavyweight rival Evander Holyfield posting his own video in response to Tyson and opening the door to a potential third fight between the pair.

Joe Rogan recently suggested that Tysons incredible speed and power was not down to natural hard work alone, and now the veteran boxer has revealed the extreme lengths he is going to in order to get back in shape.

Speaking on the Rock the Bells Radio show on SiriusXM, Tyson was asked by rapper LL Cool J how he would get in peak shape in just six to eight weeks and replied: Really I would just change my diet and just do cardio work. Cardio has to start, you have to have your endurance to go and do the process of training.

So something to do is get in cardio, I would try and get two hours of cardio a day, make sure you get that stuff in. Youre gonna make sure youre eating the right food.

For me its almost like slave food. Doing what you hate to do but doing it like its nothing. Getting up when you dont want to get up. Thats what it is. Its becoming a slave to life.

People think a slave to life is just enjoying drugs and living your life. Being a slave to life means being the best person you can be, being the best you can possibly be, and when you are at the best you can possibly be is when you no longer exist and nobody talks about you. Thats when youre at your best.

Probed further on the mental aspect of preparing for a fight, Tyson continued: My mind wouldnt belong to me. My mind would belong to somebody that disliked me enough to break my soul, and I would give them my mind for that period of time.

Six weeks of this and Id be in the best shape Ive ever dreamed of being in. As a matter of fact, Im going through that process right now. And you know what else I did, I did stem-cell research.

After LL Cool J asked if that meant Tysons white blood cells had been spun and then put back in, Tyson continued: Yes. As they took the blood it was red and when it came back it was almost transfluid [sic], I could almost see through the blood, and then they injected it in me. And Ive been weird ever since, Ive got to get balanced now.

Tyson first revealed that he had undergone stem cell treatment which is usually used to treat or prevent a disease or condition in an Instagram live chat with Shaquille ONeal earlier this month.

You know what I had done? I had stem cell therapy, said Iron Mike. I feel like a different person but I cant comprehend why I feel this way. Its really wild what scientists can do.

MORE: Evander Holyfield demands bizarre no knockouts rule for potential Mike Tyson comeback fight

MORE: Joe Rogan shocked by fu*king sensational training videos of Mike Tyson

Follow Metro Sport across our social channels, on Facebook, Twitter and Instagram.

For more stories like this, check our sport page.

View post:
Mike Tyson lifts lid on training regime and stem-cell therapy ahead of comeback - Metro.co.uk

18 May 2020

New research, in HIV positive patients being treated for blood cancer, has identified a critical time window after donor stem cell transplantation, during which the expanding donor cells are particularly vulnerable to being infected with HIV.

Patients with HIV who develop blood cancer may require treatment by allogeneic stem cell transplant, using bone marrow stem cells provided by a healthy donor. During a transplant, most of the patient's original immune cells are destroyed, and the immune system and blood cells are restored from the new donor stem cells.

'These results show a weak point that may explain why allogeneic stem cell transplants may not completely remove the virus from the body, despite a drastic reduction in the number of infected cells' saidsenior authorDr Julian Schulze zur Wiesch from the German Centre for Infection Research.

Stem cell transplantation in HIV positive patients has been the only medical intervention found to cure HIV (see BioNews 1039), however in nearly all cases HIV infection persists after transplantation.

In a new study it was discovered that immune cells generated from the donor stem cells are at risk of being infected with HIV during the first few weeks after transplantation.

In this study of 16 HIV positive participants with blood cancer, the researchers show that stem cell transplantation promotes reactivation of the virus within the patient's remaining original immune cells. This leads to some of the new immune cells becoming infected, thus 're-seeding' HIV within the host.

'Additional immunotherapy orgene therapy may be required to achieve ongoing, spontaneous control of HIV infection in people with HIV after allogeneic stem cell transplantation,' said Dr Schulze zur Wiesch.

This research was published in Science Translational Medicine.

See the original post here:
Critical window for re-infection with HIV after stem cell transplantation - BioNews

Emirati dentist with the officials Image Credit: Supplied

Ras Al Khaimah: An Emirati dentist, who received stem cell therapy after she got infected with coronavirus (COVID-19) due to transmission from a patient, was recently visited by Dr Mohamed Salim Al Olama, undersecretary of the Ministry of Health and Prevention (MoHAP) and head of the Board of Directors of the Emirates Health Services Corporation.

Dr Muhra Abdul Rahim Al-Awadi, who underwent the innovative stem cell therapy, is one of the current patients at Obaidullah Elderly Hospital in Ras Al Khaimah.

Dr Al Olama also made a series of field visits to determine the readiness of various hospitals and the conditions of medical cadres across the country, according to MoHAP.

He expressed his appreciation to Al-Awadis diligence and dedication to her homeland and called it as a national example of giving, loyalty, and sacrifice.

He added MoHAP is proud of its medical sector and it pays great attention to its employees health through the provision of the best methods of infection prevention.

According to MoHAP, Al-Awadi thanked Dr Al Olama for the visit, which pleased and motivated her to continue to work diligently after her full recovery.

She said at present she does not have any symptoms of fever or breathing difficulty and that she is recuperating after receiving stem cell therapy.

Read more from the original source:
Coronavirus: Emirati dentist who received stem cell therapy doing well - Gulf News

Israels Gamida Cell, the manufacturer of a stem cell therapy that aims to increase the success of bone marrow transplants in blood cancer patients, said on Tuesday that a key late-stage clinical trial of its treatment has yielded positive results and met a major target.

Shares of the Jerusalem-based biotech firm were up 49 percent on the Nasdaq at the open of the exchange, on the news of the potentially life-saving treatment option for patients who need bone marrow transplants.

In the multinational Phase III clinical trial, conducted at more than 50 centers around the world, blood cancer patients who received bone marrow transplants were treated with the stem-cell based therapy Omidubicel, previously called NiCord.

Get The Start-Up Israel's Daily Start-Up by email and never miss our top storiesFree Sign Up

Those who were injected with the treatment containing expanded and enhanced stem cells had a median time of neutrophil engraftment that was significantly shorter than those that did not receive the drug: 12 days compared with 22 days for patients who received a standard umbilical cord blood transplant, the company said. Neutrophil engraftment is a measure of how quickly stem cells received in a transplant are established and begin to make healthy new cells. A rapid neutrophil engraftment has been associated with fewer infections and shorter hospitalizations.

said Julian Adams, the chief executive officer of Gamida Cell (Courtesy)

I am so thrilled and excited for Gamida and for patients, said the firms CEO Julian Adams, the chief executive officer of Gamida Cell in a phone interview. Omidubicel will transform the bone marrow transplant market we will grow the market and treat more patients and hopefully have more patients cured.

The treatment was given to cancer patients in remission who needed a transplant to stop the recurrence of the disease, he said.

Among patients who were transplanted per protocol, 96 percent of patients who received Omidubicel achieved successful neutrophil engraftment, compared to 88 percent of patients in the comparative group, the company said in a statement.

Omidubicel, which would be the first drug developed by Gamida to hit the market, is believed to increase the chances of a successful bone marrow transplantation process for patients who do not have a rapidly available, fully matched bone marrow donor.

Despite the curative potential of bone marrow transplant, it is estimated that more than 40 percent of eligible patients in the United States do not receive a transplant for various reasons, including the lack of a matched donor.

Today some high-risk blood cancers cannot be cured unless the patient undergoes a bone marrow graft. For that purpose, a perfect match needs to be found, a process that in the US takes an average of three to four months, if the patient is lucky. Sometimes, no match is found.

Umbilical cord blood collected from newborn babies contains stem cells, which can be used to treat diseases. Today cord-blood banks around the world store the cord blood. Its great advantage is that because it is so young, there is no need for a full tissue matching and a partial match is enough. Most patients generally find at least one unit of cord blood that partially matches them.

The problem is that the quantity of cells in each unit is not huge, and it is the number of stem cells in the cord blood that is critical to the success of transplantation.

Gamida overcomes this limitation by expanding the number of stem cells within one unit of umbilical cord blood and enhancing their performance.

Stem cells in bag in Gamida Cells Jerusalem lab, July 2017 (Shoshanna Solomon/TimesofIsrael)

These results have the potential to substantially move the field forward and represent an important step toward making stem cell transplantation more accessible and more successful for patients with lethal blood cancers, said Dr Mitchell Horwitz, principal investigator and professor of medicine at the Duke Cancer Institute. Shortening the time to engraftment is clinically meaningful, as it can reduce a patients time in the hospital and decrease likelihood of infection.

The trial included 125 patients aged 1265 years with acute lymphoblastic leukemia, acute myelogenous leukemia, chronic myelogenous leukemia, myelodysplastic syndrome or lymphoma. It was conducted at clinical centers in the United States, Latin America, Europe and Asia.

Omidubicel has the potential to be the first FDA-approved bone marrow transplant graft, said the CEO Adams.

There are still further steps ahead, he warned, with key secondary targets that need to be met, like evaluating if the treatment can reduce the number of infections as well as cut back on hospital days. Survival endpoints will also need to be met, he said. There is a lot of work to be done, Adams added. But the primary time-to- neutrophil-engrafment target, which the company has just met, is a milestone in a journey to bring Omidubicel to patients in the market.

The firm expects to apply for a US Food and Drug Administration license to market the product in the fourth quarter of 2020, he said. And if all goes well, then the firm will be in a position to launch Omidubicel in the US market in the second half of 2021.

Omidubicel is also being evaluated in an early clinical study in patients with severe aplastic anemia, the company said.

Read more here:
Cell therapy firm boosts odds for blood cancer patients as key trial succeeds - The Times of Israel

Allosource

Stem Cell Therapy Market Competitive Analysis:

In addition, the projections offered in this report were derived using proven research assumptions and methods. In this way, the Stem Cell Therapy research study offers a collection of information and analysis for every facet of the Stem Cell Therapy market such as technology, regional markets, applications and types. The Stem Cell Therapy market report also offers some market presentations and illustrations that include pie charts, diagrams and charts that show the percentage of different strategies implemented by service providers in the Stem Cell Therapy market. In addition, the report was created using complete surveys, primary research interviews, observations and secondary research.

In addition, the Stem Cell Therapy market report introduced the market through various factors such as classifications, definitions, market overview, product specifications, cost structures, manufacturing processes, raw materials and applications. This report also provides key data on SWOT analysis, return data for investments and feasibility analysis for investments. The Stem Cell Therapy market study also highlights the extremely lucrative market opportunities that are influencing the growth of the global market. In addition, the study offers a complete analysis of market size, segmentation and market share. In addition, the Stem Cell Therapy report contains market dynamics such as market restrictions, growth drivers, opportunities, service providers, stakeholders, investors, important market participants, profile assessment and challenges of the global market.

Stem Cell Therapy Market Segments:

The report also underscores their strategics planning including mergers, acquisitions, ventures, partnerships, product launches, and brand developments. Additionally, the report renders the exhaustive analysis of crucial market segments, which includes Stem Cell Therapy types, applications, and regions. The segmentation sections cover analytical and forecast details of each segment based on their profitability, global demand, current revue, and development prospects. The report further scrutinizes diverse regions including North America, Asia Pacific, Europe, Middle East, and Africa, and South America. The report eventually helps clients in driving their Stem Cell Therapy business wisely and building superior strategies for their Stem Cell Therapy businesses.

To get Incredible Discounts on this Premium Report, Click Here @ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=24113&utm_source=COD&utm_medium=003

Table of Content

1 Introduction of Stem Cell Therapy Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Stem Cell Therapy Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Stem Cell Therapy Market, By Deployment Model

5.1 Overview

6 Stem Cell Therapy Market, By Solution

6.1 Overview

7 Stem Cell Therapy Market, By Vertical

7.1 Overview

8 Stem Cell Therapy Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Stem Cell Therapy Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Get Complete Report @ https://www.verifiedmarketresearch.com/product/Stem-Cell-Therapy-Market/?utm_source=COD&utm_medium=003

About us:

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyse data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defence, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact us:

Mr. Edwyne Fernandes

US: +1 (650)-781-4080UK: +44 (203)-411-9686APAC: +91 (902)-863-5784US Toll Free: +1 (800)-7821768

Email: [emailprotected]

Tags: Stem Cell Therapy Market Size, Stem Cell Therapy Market Trends, Stem Cell Therapy Market Growth, Stem Cell Therapy Market Forecast, Stem Cell Therapy Market Analysis NMK, Majhi Naukri, Sarkari Naukri, Sarkari Result

Our Trending Reports

Metabolomics Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Stem Cell Therapy Market Size, Growth Analysis, Opportunities, Business Outlook and Forecast to 2026

Visit link:
Stem Cell Therapy Market Research Report 2020 By Size, Share, Trends, Analysis and Forecast to 2026 - Cole of Duty

The recent report on Cell Freezing Media for Cell Therapy market provides an end-to-end assessment of this business sphere and comprises of important data regarding the pivotal parameters such as prevailing market trends, current revenue, market share, industry size, periodic deliverables, and profit estimates over the forecast duration.

New latest Growth Report on Cell Freezing Media for Cell Therapy Market Size, Share | Industry Segment by Applications (Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation and Other), by Type (With FBS and Without FBS), Regional Outlook, Market Demand, Latest Trends, Industry Growth & Revenue by Manufacturers, Company Profiles & Forecasts to 2025. Analyzes current market size and upcoming 5 years growth of this industry.

A thorough examination of the behavior patterns of the Cell Freezing Media for Cell Therapy market over the projected timeframe has been laid out in the report. Insights about various aspects that shape the market dynamics, alongside the growth rate projections of the industry over the forecast period in enclosed in the report. The report further elaborates challenges encountered by this industry vertical, in conjunction with the growth prospects that could propel the industry growth over the forecast timeline.

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/189523

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

Unveiling the Cell Freezing Media for Cell Therapy market with respect to the geographical landscape:

Cell Freezing Media for Cell Therapy Market segmentation:

A brief summary of regional terrain:

A comprehensive study of Cell Freezing Media for Cell Therapy market with respect to the product type and application spectrum:

Product scope:

Product types:

Key insights of the report:

Application scope:

Application segmentation:

Specifics provided in the report:

Other takeaways from the Cell Freezing Media for Cell Therapy market report:

Elucidating details about the competitive outlook of the Cell Freezing Media for Cell Therapy market:

Major players of the industry:

Key parameters enlisted in the report:

Research objectives:

This report considers the below mentioned key questions:

Q.1. What are some of the most favorable, high-growth prospects for the global Cell Freezing Media for Cell Therapy market?

Q.2. Which products segments will grow at a faster rate throughout the forecast period and why?

Q.3. Which geography will grow at a faster rate and why?

Q.4. What are the major factors impacting market prospects? What are the driving factors, restraints, and challenges in this Cell Freezing Media for Cell Therapy market?

Q.5. What are the challenges and competitive threats to the market?

Q.6. What are the evolving trends in this Cell Freezing Media for Cell Therapy market and reasons behind their emergence?

Q.7. What are some of the changing customer demands in the Cell Freezing Media for Cell Therapy Industry market?

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/189523

View post:
Cell Freezing Media for Cell Therapy Market to Exhibit Impressive Growth of CAG - News by aeresearch

An assistant parish priest in the UAE has died after suffering from multiple complications arising from Covid-19.

Father Youssef Sami Youssef, 62, served the Arabic-speaking community at St Michaels Church Sharjah.

The outgoing and lively priest had been receiving treatment, including ventilation and stem-cell therapy, at Sheikh Khalifa Medical City, Ajman.

But his condition continued to deteriorate and he died on Sunday as a result of multiple organ failure.

Fr Youssef was under treatment for almost three weeks at the multi-speciality hospital and received expert care, ventilation and stem cell therapy, the Apostolic Vicariate of Southern Arabia said.

However since he already had some underlying medical conditions, he soon started to develop critical multiple organ failure.

The vicariate said his outgoing and lively personality would be sorely missed by all who knew him, especially the Arabic and French-speaking Catholics in the vicariate, where he served several churches throughout his career.

More than 700 parishioners paid tribute to Fr Youssef on the vicariates Facebook page, where his death was announced to his congregation.

May his soul rest in peace. I used to attend his Masses when he served in Abu Dhabi, wrote one.

Father Youssef was a humble man, I heard that he lived a difficult life, as he lost so many family members in the Lebanese war, yet he kept the faith.

He is without a doubt in the Lord's heavens. A good humble man he was, a faithful priest and a caring soul. May God have mercy on your soul Father. We will miss you.

Another wrote he would remember his smile.

Even though I never interacted with him so much ... but he was one person I came across with a smile when I used to see him before the Sunday 8pm Mass. Rest in peace, Father.

Born in Lebanon in 1957, Father Youssef joined the Order of Friars Minor Capuchin of the General Custody of the Near East in 1977, and was ordained to the priesthood 11 years later.

He had been a missionary in the Gulf region since 1993, and served several UAE communities, including St Marys Church in Dubai, St Josephs Cathedral Abu Dhabi and St Marys Church Al Ain.

He was also stationed in Doha and Manama for a time between 2004 and 2011. But since 2016, he served St Micheals Church Sharjah.

Details of his burial and memorial Mass have yet to be made public.

Updated: May 18, 2020 03:31 PM

Go here to read the rest:
Coronavirus: assistant parish priest in Sharjah dies from complications of the disease - The National

Los Angeles, United StatesThe report offers an all-inclusive and accurate research study on the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market while chiefly focusing on current and historical market scenarios. Stakeholders, market players, investors, and other market participants can significantly benefit from the thorough market analysis provided in the report. The authors of the report have compiled a detailed study on crucial market dynamics, including growth drivers, restraints, and opportunities. This study will help market participants to get a good understanding of future development of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. The report also focuses on market taxonomy, regional analysis, opportunity assessment, and vendor analysis to help with comprehensive evaluation of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market.

Key companies operating in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market include : , Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Anderson Center for Hair, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, Virginia Surgical Center, Hair Transplant Institute of Miami, Colorado Surgical Center & Hair Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1698362/covid-19-impact-on-global-stem-cell-and-platelet-rich-plasma-prp-alopecia-therapies-market

Segment Analysis

The segmental analysis will help companies to focus on high-growth areas of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market. In order to broaden the overall understanding of the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry, the report has segregated the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies business into varied segments comprising product type, application, and end user. This examination has been carried out based on parameters like size, CAGR, share, production, and consumption. Also, region-wise assessment, wherein lucrative prospects that a region or country is likely to offer has been explored.

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Segment By Type:

, Platelet Rich Plasma Injections, Stem Cell Therapy Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Segment By Application:

, Platelet Rich Plasma Injections, Stem Cell Therapy Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Competitive Landscape:

It is important for every market participant to be familiar with the competitive scenario in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies market include : , Orange County Hair Restoration Center, Hair Sciences Center of Colorado, Anderson Center for Hair, Evolution Hair Loss Institute, Savola Aesthetic Dermatology Center, Virginia Surgical Center, Hair Transplant Institute of Miami, Colorado Surgical Center & Hair Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies

Key Questions Answered

Enquire for Customization in this Report: https://www.qyresearch.com/customize-request/form/1698362/covid-19-impact-on-global-stem-cell-and-platelet-rich-plasma-prp-alopecia-therapies-market

Table of Contents

1 Report Overview1.1 Study Scope1.2 Key Market Segments1.3 Players Covered: Ranking by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue1.4 Market Analysis by Type1.4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size Growth Rate by Type: 2020 VS 20261.4.2 Platelet Rich Plasma Injections1.4.3 Stem Cell Therapy1.5 Market by Application1.5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Application: 2020 VS 20261.5.2 Dermatology Clinics1.5.3 Hospitals1.6 Coronavirus Disease 2019 (Covid-19): Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry Impact1.6.1 How the Covid-19 is Affecting the Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Industry

1.6.1.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business Impact Assessment Covid-19

1.6.1.2 Supply Chain Challenges

1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products1.6.2 Market Trends and Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Potential Opportunities in the COVID-19 Landscape1.6.3 Measures / Proposal against Covid-19

1.6.3.1 Government Measures to Combat Covid-19 Impact

1.6.3.2 Proposal for Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players to Combat Covid-19 Impact1.7 Study Objectives1.8 Years Considered 2 Global Growth Trends by Regions2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Perspective (2015-2026)2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Growth Trends by Regions2.2.1 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Regions: 2015 VS 2020 VS 20262.2.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Share by Regions (2015-2020)2.2.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Regions (2021-2026)2.3 Industry Trends and Growth Strategy2.3.1 Market Top Trends2.3.2 Market Drivers2.3.3 Market Challenges2.3.4 Porters Five Forces Analysis2.3.5 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Growth Strategy2.3.6 Primary Interviews with Key Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players (Opinion Leaders) 3 Competition Landscape by Key Players3.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Market Size3.1.1 Global Top Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Players by Revenue (2015-2020)3.1.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue Market Share by Players (2015-2020)3.1.3 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio3.2.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Concentration Ratio (CR5 and HHI)3.2.2 Global Top 10 and Top 5 Companies by Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Revenue in 20193.3 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players Head office and Area Served3.4 Key Players Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Product Solution and Service3.5 Date of Enter into Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)4.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Historic Market Size by Type (2015-2020)4.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Type (2021-2026) 5 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Breakdown Data by Application (2015-2026)5.1 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020)5.2 Global Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Forecasted Market Size by Application (2021-2026) 6 North America6.1 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)6.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in North America (2019-2020)6.3 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)6.4 North America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 7 Europe7.1 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)7.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Europe (2019-2020)7.3 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)7.4 Europe Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 8 China8.1 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)8.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in China (2019-2020)8.3 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)8.4 China Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 9 Japan9.1 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)9.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Japan (2019-2020)9.3 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)9.4 Japan Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 10 Southeast Asia10.1 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)10.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Southeast Asia (2019-2020)10.3 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)10.4 Southeast Asia Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 11 India11.1 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)11.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in India (2019-2020)11.3 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)11.4 India Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 12 Central & South America12.1 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size (2015-2020)12.2 Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Key Players in Central & South America (2019-2020)12.3 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Type (2015-2020)12.4 Central & South America Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Size by Application (2015-2020) 13 Key Players Profiles13.1 Orange County Hair Restoration Center13.1.1 Orange County Hair Restoration Center Company Details13.1.2 Orange County Hair Restoration Center Business Overview and Its Total Revenue13.1.3 Orange County Hair Restoration Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.1.4 Orange County Hair Restoration Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020))13.1.5 Orange County Hair Restoration Center Recent Development13.2 Hair Sciences Center of Colorado13.2.1 Hair Sciences Center of Colorado Company Details13.2.2 Hair Sciences Center of Colorado Business Overview and Its Total Revenue13.2.3 Hair Sciences Center of Colorado Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.2.4 Hair Sciences Center of Colorado Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.2.5 Hair Sciences Center of Colorado Recent Development13.3 Anderson Center for Hair13.3.1 Anderson Center for Hair Company Details13.3.2 Anderson Center for Hair Business Overview and Its Total Revenue13.3.3 Anderson Center for Hair Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.3.4 Anderson Center for Hair Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.3.5 Anderson Center for Hair Recent Development13.4 Evolution Hair Loss Institute13.4.1 Evolution Hair Loss Institute Company Details13.4.2 Evolution Hair Loss Institute Business Overview and Its Total Revenue13.4.3 Evolution Hair Loss Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.4.4 Evolution Hair Loss Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.4.5 Evolution Hair Loss Institute Recent Development13.5 Savola Aesthetic Dermatology Center13.5.1 Savola Aesthetic Dermatology Center Company Details13.5.2 Savola Aesthetic Dermatology Center Business Overview and Its Total Revenue13.5.3 Savola Aesthetic Dermatology Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.5.4 Savola Aesthetic Dermatology Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.5.5 Savola Aesthetic Dermatology Center Recent Development13.6 Virginia Surgical Center13.6.1 Virginia Surgical Center Company Details13.6.2 Virginia Surgical Center Business Overview and Its Total Revenue13.6.3 Virginia Surgical Center Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.6.4 Virginia Surgical Center Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.6.5 Virginia Surgical Center Recent Development13.7 Hair Transplant Institute of Miami13.7.1 Hair Transplant Institute of Miami Company Details13.7.2 Hair Transplant Institute of Miami Business Overview and Its Total Revenue13.7.3 Hair Transplant Institute of Miami Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.7.4 Hair Transplant Institute of Miami Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.7.5 Hair Transplant Institute of Miami Recent Development13.8 Colorado Surgical Center & Hair Institute13.8.1 Colorado Surgical Center & Hair Institute Company Details13.8.2 Colorado Surgical Center & Hair Institute Business Overview and Its Total Revenue13.8.3 Colorado Surgical Center & Hair Institute Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Introduction13.8.4 Colorado Surgical Center & Hair Institute Revenue in Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Business (2015-2020)13.8.5 Colorado Surgical Center & Hair Institute Recent Development 14 Analysts Viewpoints/Conclusions 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Disclaimer15.3 Author Details

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Read the original here:
Stem Cell and Platelet Rich Plasma (PRP) Alopecia Therapies Market Review Study,Indepth Analysis is Available in Recent Research Report During...

A Coventry woman has set up a Go Fund Me page in the hope of raising money for treatment which has the potential to change her mother's quality of life.

Leyla Hassan and her family own a fish and chip shop in Tile Hill called the Station Plaice Fish Bar. They have owned the business for many years with her mum and dad running it on a daily basis.

However the Hassan family's lives got turned upside down when mother Dalga Hassan, 54, got diagnosed with Primary Progressive Multiple Sclerosis (MS) three years ago.

Sadly since the diagnosis, Dalga's condition has deteriorated, to the point where she can no longer walk or be independent.

Daughter, Layla, 31, has had to move back into the family home to help offer support to her mother as she has suffered with the illness.

Layla said: "My mum and dad run Station Plaice Fish Bar in Tile Hill, but three years ago my mum was diagnosed with MS.

"Over the past six or seven months she could walk but now she can't at all, she can't do anything for herself.

"My mum can't even go to the toilet on her own and she is desperate to do something on her own."

Dalga is a mother to three children and used to work in the family shop alongside her husband six days a week serving customers.

Now she sits at the back of the shop in the day, chatting to customers.

Leyla, who works in sales for car manufacturer BMW, continued: "Before the MS she used to work in the fish shop six days a week. Now, she will go down in the morning using her chairlift and sit in a chair at the back of the shop.

"It's so hard seeing someone that used to move and work at 100 miles an hour be like this. She always used to be cooking and cleaning for us and doing all sorts of things.

"However, our customers in the shop ask for my mum all the time and will always go and talk to her."

You can get your Coventry and Warwickshire news straight to your email inbox - and it's FREE!

All you need to do is bump your email in at the top of the article - it looks just like this...

The emails come out once a day, at lunchtime, with the latest news, what's on and sport.

The family are beginning to struggle with Dalga's condition and have been looking for different treatment methods that may be able to help.

"We have been asking the doctors here in the UK if she could take part in any trials, anything that might make her condition better but we just keep getting told no," Leyla said.

"So I did some research into different treatments across the world and stumbled on stem cell therapy. A lot of people that have MS and have had the treatment find their mobility becomes better as a result."

The family are attempting to raise 40,000 to send Dalga to Turkey to receive potentially life-changing stem cell treatment, which may improve her quality of life.

Leyla added: "The treatment is similar to chemotherapy, in the sense that it wipes out your immune system. That means my mum may loose her hair.

"So, if we reach the 40k mark and she is able to go, I'm going to shave my head so she doesn't have to go through it alone."

Leyla explains the family have also been in contact with Coventry City Council about getting a wet room fitted in place of their shower.

She said: "Someone came round to look at the flat and said we needed a wet room. They said it would be a six month wait but we have waited much longer than that.

"We appreciate the coronavirus situation has slowed everything down, but the week after someone came round to assess our bathroom, my mum fell out of the shower and I had to call an ambulance.

"I couldn't lift her on her own as it is like lifting a dead weight. It was really scary."

A spokesperson for Coventry City Council said: There is high demand for disabled adaptations in Coventry and as a result there is a waiting list. With the social distancing measures introduced as a result of Covid-19 this has extended the period further.

"There is a priority system in place for those with high level of risk and as some contractors are now returning to work these cases will be progressed.

So far, the Hassan family have raised around 3,000 of their 40,000 target.

"I really wanted to run some fundraising events. But given the current circumstances that just can't happen", Leyla said.

The family are desperate to send their mother to Turkey for treatment and say they are grateful for any donation.

If you would like to donate online, you can do so here.

Equally, the family are more than happy to take donations and speak to people at their chip shop located on Station Avenue in Tile Hill.

Continue reading here:
Family needs to raise 40k towards potentially life-changing treatment for mum with MS - Coventry Telegraph

Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available onlineThursday calling the shots. Earnings news flow continued to taper.

Biopharma companies working on vaccines/therapies for COVID-19 continued to provide updates. Novavax, Inc. (NASDAQ: NVAX) shares more than doubled, thanks to an announcement concerning a $384 million grant from the Coalition for Epidemic Preparedness Innovations.

Here are the key catalysts for the unfolding week.

The FDA is due to rule on Aquestive Therapeutics Inc's (NASDAQ: AQST) NDA for apomorphine sublingual film (APL-130277), which is being evaluated for treating off episodes in Parkinson's disease patients. APL-130277 is being developed by Sunovion Pharmaceuticals, a subsidiary of Sumitomo Dainippon Pharma, in partnership with Aquestive.

Entera Bio Ltd (NASDAQ: ENTX) is scheduled to report on Thursday interim three-month top-line biomarker data for the first 50% of the patients enrolled in the Phase 2 osteoporosis clinical trial of EB613.

Oncolytics Biotech, Inc. (NASDAQ: ONCY) is due to present at the ESMO Breast Cancer Conference, interim biomarker data from the AWARE-1 early-stage breast cancer study that is evaluating its pelareorep along with Roche Holdings AG's(OTC: RHHBY) Tecentriq.

See Also: Results From Oxford University's Human Trial Of Coronavirus Vaccine Could Arrive In June; Where Inovio, Moderna Stand

Monday

Milestone Scientific Inc. (NYSE: MLSS) (before the market open)Adamis Pharmaceuticals Corp (NASDAQ: ADMP) (after the close)

Tuesday

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (after the close)Ascendis Pharma A/S (NASDAQ: ASND) (after the close)

Wednesday

Mediwound Ltd (NASDAQ: MDWD) (before the market open)China Biologic Products Holdings Inc (NASDAQ: CBPO) (after the close)

Thursday

Entera Bio (before the market open)Medtronic PLC (NYSE: MDT) (before the market open)PAVmed Inc (NASDAQ: PAVM) (after the close)Xenon Pharmaceuticals Inc (NASDAQ: XENE) (after the close)

ORIC Pharmaceuticals Inc (NASDAQ: ORIC)

2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original post:
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows - Benzinga